Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRUSADERS fluid and salt reduction trial in critically ill adults
2025-520744-14-00Phase 4Authorised
- Sponsor
- Antwerp University Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dextrose + sodium chloride, plasma-lyte, glucose and sodium chloride in critical illness (2 arms), sponsored by Antwerp University Hospital. Primary endpoint: Days alive and without life support at 90 days. Planned start Oct 2025; status: authorised.
02
Drugs
dextrose + sodium chlorideplasma-lyteglucosesodium chloride
03
Conditions
critical illness
Beyond the preview
Go deeper on 2025-520744-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520744-14-00.